Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.20−0.15 (-42.59%)
Close on Nov 13, 2026Market cap $906.90KP/E –Yield –
Oragenics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oragenics's enterprise value was -$2.33M on Nov 11, 2026, against -$7.81M a year earlier. Over the last 5 years it ranged from -$8.17M to $16.14B, with a median of $137.74M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.33M | – |
| 2025 | Dec 31, 2025 | -$8.17M | -108.1% |
| 2024 | Dec 31, 2024 | $100.87M | -76.4% |
| 2023 | Dec 29, 2023 | $427.96M | +10.7% |
| 2022 | Dec 30, 2022 | $386.50M | -75.6% |
| 2021 | Dec 31, 2021 | $1.58B | +88.2% |
| 2020 | Dec 31, 2020 | $839.94M | +15.6% |
| 2019 | Dec 31, 2019 | $726.29M | +52.2% |
| 2018 | Dec 31, 2018 | $477.05M | +33.9% |
| 2017 | Dec 29, 2017 | $356.25M | -56.4% |
| 2016 | Dec 30, 2016 | $817.89M | -51.6% |
| 2015 | Dec 31, 2015 | $1.69B | +71.3% |
| 2014 | Dec 31, 2014 | $987.51M | -62.3% |
| 2013 | Dec 31, 2013 | $2.62B | +18.3% |
| 2012 | Dec 31, 2012 | $2.22B | +1144.7% |
| 2011 | Dec 30, 2011 | $178.13M | – |
See a number that looks wrong?